umbralisib
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for umbralisib, covering 2022-07-21 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma [Phase 2]